NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
13.85
Dollar change
-0.31
Percentage change
-2.19
%
Index- P/E- EPS (ttm)-0.51 Insider Own15.84% Shs Outstand33.44M Perf Week-11.45%
Market Cap482.34M Forward P/E21.69 EPS next Y0.64 Insider Trans0.00% Shs Float29.31M Perf Month-22.93%
Enterprise Value424.46M PEG- EPS next Q0.03 Inst Own40.68% Short Float2.58% Perf Quarter-1.07%
Income-14.21M P/S8.96 EPS this Y106.45% Inst Trans29.41% Short Ratio1.52 Perf Half Y13.34%
Sales53.85M P/B5.77 EPS next Y964.28% ROA-23.02% Short Interest0.76M Perf YTD15.03%
Book/sh2.40 P/C8.19 EPS next 5Y- ROE-29.95% 52W Range7.17 - 18.23 Perf Year79.17%
Cash/sh1.69 P/FCF- EPS past 3/5Y36.35% 69.36% ROIC-17.51% 52W High-24.03% Perf 3Y270.32%
Dividend Est.- EV/EBITDA- Sales past 3/5Y118.74% 88.10% Gross Margin84.90% 52W Low93.16% Perf 5Y64.10%
Dividend TTM- EV/Sales7.88 EPS Y/Y TTM81.29% Oper. Margin-2.77% Volatility2.46% 2.94% Perf 10Y-100.00%
Dividend Ex-Date- Quick Ratio14.61 Sales Y/Y TTM1068.87% Profit Margin-26.38% RSI (14)37.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio15.95 EPS Q/Q106.07% SMA20-12.70% Beta0.93 Target Price24.29
Payout- Debt/Eq0.01 Sales Q/Q530.26% SMA50-2.78% Rel Volume1.40 Prev Close14.16
Employees96 LT Debt/Eq0.01 EarningsMay 08 BMO SMA20010.83% Avg Volume498.77K Price13.85
IPOOct 23, 2001 Option/ShortYes / Yes EPS/Sales Surpr.40.19% 18.32% Trades Volume699,336 Change-2.19%
Date Action Analyst Rating Change Price Target Change
Jun-28-24Initiated Craig Hallum Buy $18
May-14-24Initiated Stephens Overweight $25
Jul-26-22Resumed Canaccord Genuity Buy $17
Dec-10-21Initiated H.C. Wainwright Buy $25
Mar-09-21Initiated Canaccord Genuity Buy $24
Jan-05-21Initiated BTIG Research Buy $23
Jun-01-20Initiated Laidlaw Buy $19
Jun-04-25 12:00PM
09:40AM
May-28-25 09:55AM
08:50AM
May-22-25 07:00AM
04:30PM Loading…
May-15-25 04:30PM
May-09-25 05:30PM
03:15AM
May-08-25 08:45AM
07:30AM
May-07-25 06:00PM
02:21PM
May-06-25 07:10AM
Apr-28-25 08:30AM
Apr-27-25 09:22AM
04:01PM Loading…
Apr-24-25 04:01PM
Apr-10-25 09:03AM
Apr-09-25 05:00PM
Apr-02-25 11:49AM
Mar-27-25 04:45PM
10:46AM
Mar-26-25 09:55AM
Mar-24-25 04:01PM
Mar-19-25 09:40AM
Mar-14-25 04:01PM
Mar-06-25 08:00AM
Feb-20-25 08:30AM
Feb-14-25 08:30AM
Jan-31-25 07:00AM
Jan-28-25 04:01PM
02:31PM Loading…
Jan-15-25 02:31PM
Jan-13-25 08:00AM
Jan-03-25 04:01PM
Dec-30-24 08:00AM
Dec-02-24 08:30AM
Nov-09-24 04:00PM
Nov-08-24 08:00AM
Nov-01-24 04:01PM
Oct-25-24 08:30AM
Oct-17-24 08:30AM
Sep-20-24 04:01PM
Sep-16-24 08:30AM
Aug-28-24 04:01PM
04:01PM
Aug-27-24 08:30AM
Aug-26-24 04:01PM
Aug-20-24 08:30AM
Aug-12-24 04:01PM
Aug-05-24 08:59PM
04:01PM
08:30AM
Jul-30-24 04:01PM
Jul-22-24 04:01PM
Jul-15-24 12:00PM
Jun-14-24 08:50AM
Jun-03-24 09:55AM
May-28-24 09:30AM
May-17-24 09:55AM
May-15-24 08:50AM
03:02AM
May-14-24 11:52AM
07:30AM
May-07-24 08:30AM
May-06-24 09:00AM
May-03-24 05:15PM
Apr-23-24 09:55AM
Apr-05-24 09:55AM
Apr-04-24 08:35AM
Apr-02-24 12:00PM
Mar-27-24 11:50AM
Mar-26-24 11:52AM
09:12AM
08:40AM
07:30AM
Mar-22-24 02:43PM
Mar-20-24 08:15AM
Mar-19-24 09:00AM
Mar-18-24 05:20PM
Mar-15-24 08:20AM
Mar-08-24 05:00PM
09:00AM
Feb-22-24 05:00PM
Feb-16-24 05:00PM
Jan-31-24 08:00AM
Jan-23-24 08:00AM
Jan-16-24 08:00AM
Jan-12-24 05:00PM
Dec-15-23 01:02PM
Dec-07-23 09:00AM
Nov-15-23 05:00PM
Nov-13-23 04:05PM
Nov-06-23 04:30PM
Oct-16-23 08:30AM
Oct-10-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 04:05PM
Sep-14-23 09:59AM
Sep-11-23 08:00AM
Sep-05-23 04:00PM
Sep-01-23 02:07PM
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vukovic VojoCHIEF MEDICAL OFFICERJun 12 '25Option Exercise4.7842,000200,760168,882Jun 13 05:22 PM
MICHEL GERARD JCHIEF EXECUTIVE OFFICEROct 22 '24Option Exercise6.0016,66699,996319,334Oct 23 04:17 PM